Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01020682

Enrollment

120

Registered

2009-11-25

Start date

2005-01-31

Completion date

2011-06-30

Last updated

2009-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apathy in Parkinson Disease

Keywords

apathy, parkinson, agonist dopaminergic

Brief summary

Apathy has been reported to occur after subthalamic nucleus stimulation (STN-DBS), a treatment of motor complications in advanced Parkinson's disease (PD). It is not known whether postoperative apathy is related to dopamine withdrawal or a side effect of STN DBS. The researchers investigated potential predictors of apathy, and the effect of dopamine agonist treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Parkinson disease

Exclusion criteria

* Mattis scale \< 130 * Beck scale \> 20

Countries

France

Contacts

Primary ContactKrack Paul, MD

paul.krack@ujf-grenoble.fr0476765791

Outcome results